Cell Lysis Market Worth 3.84 Billion | Growing Focus on Personalized Medicine & High Prevalence of Diseases

PUNE, India, 2020-Jun-03 — /EPR Network/ —

The  research report on “Cell Lysis/Cell Fractionation Market by Product (Consumables (Reagents, Enzymes, Detergent), Instruments (Sonicator, Homogenizer)), Type of Cell (Microbial, Mammalian), End User (Research Laboratories, Biopharmaceutical & Biotechnology Companies) – Global Forecast” , report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the cell lysis market along with the estimates and forecasts of the revenue and market share analysis.

The Global Cell Lysis Market is expected to reach $3.84 Billion, at a CAGR of 10.3% during the forecast period.

The global Cell Fractionation Market consists of various products that are used for extraction of nucleic material, proteins and other cell content. This market is driven by several factors such as increasing government funding for research, high prevalence of diseases, expanding biotechnology and biopharmaceutical industries, and growing focus on personalized medicine. High potential growth in emerging markets has opened an array of opportunities for the market.

Browse 84 market data Tables and 41 Figures spread through 135 Pages and in-depth TOC – Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=260138321

Market Segmentation in Depth:

On the basis of product, the cell lysis market is segmented into consumables and instruments. The consumables segment is expected to account for the largest share of the global market. Consumables include reagents and kits, beads, and disposables. Reagents and kits are further classified into enzymes, detergent solutions, and other reagents and kits. Enzymes are mostly used for chemical cell disruption and form major portion of the reagents and kits market. The instruments segment comprises sonicators, homogenizers, and other instruments. Sonicators account for largest share of the instruments market owing to its increasing use in cell fractionation. However, high cost of sonicators hinders its growth.

On the basis of type of cell, the cell lysis market is segmented into mammalian cells, microbial cells, and other cells. The mammalian cells segment is expected to account for the largest share of this market, owing to rising investments by governments and companies for cell-based research. Rising prevalence of diseases such as cancer, HIV/AIDS urges a demand for advanced treatment options and development of cell therapies. This increases the market growth of mammalian and microbial cells.

End-users, included in the Cell Fractionation Market are research laboratories and institutes, biopharmaceutical and biotechnology companies, and others. The research laboratories and institutes segment is expected to account for the largest share of the global market. Rise in funding and grants by government organizations such as National Institutes of Health (NIH) for stem cell and other cell-based research has resulted in the increasing use of cell analysis and fractionation products in research institutes.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=260138321

Based on regions, the global cell lysis market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America is expected to account for the largest share of the market during the forecast period. Growth in this regional segment is driven by factors such as increase in aging population, and increasing government funding in North America.

Key players in the Cell Fractionation Market include Beckman Coulter, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Cell Signaling Technology, Inc. (U.S.), F. Hoffman-La Roche AG (Switzerland), Merck KGaA (Germany), Miltenyi Biotec (Germany), QIAGEN N.V. (Netherlands), Qsonica, LLC. (U.S.), and Thermo Fisher Scientific Inc. (U.S.).